Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for ZimVie Inc. (ZIMV : NSDQ)

• Company Description    ZimVie Inc. involved in the Dental and Spine markets which develops, manufactures and delivers a portfolio of products and solutions designed to treat Spine pathologies and support Dental tooth replacement and restoration procedures. ZimVie Inc. is headquartered in Westminster, Colorado. Number of Employees: 1,770

• Price / Volume Information    Yesterday's Closing Price: $18.88 Daily Weekly Monthly 20 Day Moving Average: 641,887 shares Shares Outstanding: 28.21 (millions) Market Capitalization: $532.62 (millions) Beta: 2.19 52 Week High: $19.01 52 Week Low: $8.15 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 0.27% -1.54% 12 Week 119.28% 99.09% Year To Date 35.34% 20.84%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 4555 RIVERSIDE DRIVE - PALM BEACH GARDEN,FL 33410 USA ph: 800-342-5454 fax: - marissa@gilmartinir.com http://www.zimvie.com

• General Corporate Information    Officers Vafa Jamali - President; Chief Executive Officer and Director Richard Heppenstall - Executive Vice President; Chief Financial Officer Sandra Schneider - Chief Accounting Officer Vinit Asar - Director Sally Crawford - Director Peer Information ZimVie Inc. (BJCT) ZimVie Inc. (CADMQ) ZimVie Inc. (APNO) ZimVie Inc. (UPDC) ZimVie Inc. (IMTIQ) ZimVie Inc. (CYGN) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED PRODUCTS Sector: Medical CUSIP: 98888T107 SIC: 3843 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/25 Next Expected EPS Date: 10/29/25 Share - Related Items Shares Outstanding: 28.21 Most Recent Split Date: (:1) Beta: 2.19 Market Capitalization: $532.62 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: 0.00 Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: 0.00 Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 10/29/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: 20.52 PEG Ratio: - Price Ratios Price/Book: 1.29 Price/Cash Flow: 10.16 Price / Sales: 1.20 EPS Growth vs. Year Ago Period: 100.00% vs. Previous Quarter: -3.70% Sales Growth vs. Year Ago Period: -0.13% vs. Previous Quarter: 4.17% ROE 06/30/25 - 6.37 03/31/25 - 5.53 12/31/24 - 4.22 ROA 06/30/25 - 3.34 03/31/25 - 2.84 12/31/24 - 1.90 Current Ratio 06/30/25 - 2.37 03/31/25 - 2.14 12/31/24 - 1.92 Quick Ratio 06/30/25 - 1.60 03/31/25 - 1.48 12/31/24 - 1.36 Operating Margin 06/30/25 - 5.73 03/31/25 - 4.91 12/31/24 - 3.69 Net Margin 06/30/25 - -4.39 03/31/25 - -4.40 12/31/24 - -5.74 Pre-Tax Margin 06/30/25 - -1.96 03/31/25 - -3.55 12/31/24 - -5.25 Book Value 06/30/25 - 14.64 03/31/25 - 14.19 12/31/24 - 13.83 Inventory Turnover 06/30/25 - 1.96 03/31/25 - 2.07 12/31/24 - 2.16 Debt-to-Equity 06/30/25 - 0.56 03/31/25 - 0.58 12/31/24 - 0.60 Debt-to-Capital 06/30/25 - 35.87 03/31/25 - 36.68 12/31/24 - 37.46

Powered by Zacks Investment Research ©